CTA-Sticky-button.png clinicaltrialsyearbook+button

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player


Packaging & Serialization

A quick overview

Serialization is the assignment and placement of unique markings on primary packaging. This includes two-dimensional or RSS bar codes, letters/number code or unique serialized codes that can be ‘written’ onto radio-frequency identification (RFID) label. These labels can also be linked to one-an-other and are then available to pharmacists, law enforcements and consumers in the post-shipping process.

Why should we use it?

 As serialization enables the tracking and linking along the supply chain, it shares many of the same benefits as UDIs present for medical devices. 

As well as protecting against counterfeiting (protecting both the brand and the patient), theft, diversion and false returns to manufacturers, it aids supply chain integrity and regulatory compliance.

It is important not to overlook the strategy alterations required as a result, as further processes along the line are affected. This is especially true within distribution as regulation states that data must be captured.  As the dynamics are changed and complexities are added, the tendency to outsource may be seen. A wider industry shift can also be expected as customers seek to cut out the pharmacist as the middle man, and buy online. Serialization aids this customer engagement process.

One of the biggest challenges is the diversity of regulations between countries. It is important to consider international legislations to identify similarities and contrasts to support the understanding of key restrictions to integrate internally. However, the ever-developing nature of regulations requires continual updates and adaptation.  

 We will be joined by Mike Zojaji, Product Launch Manager from Bayer, a Life Science company with more than 150 years experience within healthcare and agriculture. Their aim is to improve “people’s quality of life by preventing, alleviating and treating diseases.” He will be looking at “taking a holistic view of your serialization, anti-counterfeiting and diversion to build a robust supply chain to patient”.

View the full program here